Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

1.

Having pancreatic cancer with tumoral loss of ATM and normal TP53 protein expression is associated with a poorer prognosis.

Kim H, Saka B, Knight S, Borges M, Childs E, Klein A, Wolfgang C, Herman J, Adsay VN, Hruban RH, Goggins M.

Clin Cancer Res. 2014 Apr 1;20(7):1865-72. doi: 10.1158/1078-0432.CCR-13-1239. Epub 2014 Jan 31.

PMID:
24486587
[PubMed - in process]
2.

The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Tascilar M, Skinner HG, Rosty C, Sohn T, Wilentz RE, Offerhaus GJ, Adsay V, Abrams RA, Cameron JL, Kern SE, Yeo CJ, Hruban RH, Goggins M.

Clin Cancer Res. 2001 Dec;7(12):4115-21.

PMID:
11751510
[PubMed - indexed for MEDLINE]
Free Article
3.

Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.

Hustinx SR, Fukushima N, Zahurak ML, Riall TS, Maitra A, Brosens L, Cameron JL, Yeo CJ, Offerhaus GJ, Hruban RH, Goggins M.

Cancer Biol Ther. 2005 May;4(5):596-601. Epub 2005 May 13.

PMID:
15908786
[PubMed - indexed for MEDLINE]
Free Article
4.

Prognostic significance of maspin in pancreatic ductal adenocarcinoma: tissue microarray analysis of 223 surgically resected cases.

Cao D, Zhang Q, Wu LS, Salaria SN, Winter JW, Hruban RH, Goggins MS, Abbruzzese JL, Maitra A, Ho L.

Mod Pathol. 2007 May;20(5):570-8. Epub 2007 Mar 30.

PMID:
17396143
[PubMed - indexed for MEDLINE]
Free Article
5.

Ataxia-telangiectasia-mutated protein expression with microsatellite instability in gastric cancer as prognostic marker.

Kim JW, Im SA, Kim MA, Cho HJ, Lee DW, Lee KH, Kim TY, Han SW, Oh DY, Lee HJ, Kim TY, Yang HK, Kim WH, Bang YJ.

Int J Cancer. 2014 Jan 1;134(1):72-80. doi: 10.1002/ijc.28245. Epub 2013 Sep 17.

PMID:
23649938
[PubMed - indexed for MEDLINE]
6.

Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.

Infante JR, Matsubayashi H, Sato N, Tonascia J, Klein AP, Riall TA, Yeo C, Iacobuzio-Donahue C, Goggins M.

J Clin Oncol. 2007 Jan 20;25(3):319-25.

PMID:
17235047
[PubMed - indexed for MEDLINE]
Free Article
7.

Tumoral epithelial and stromal expression of SMAD proteins in pancreatic ductal adenocarcinomas.

Handra-Luca A, Hammel P, Sauvanet A, Ruszniewski P, Couvelard A.

J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):294-302. doi: 10.1007/s00534-012-0518-6.

PMID:
22581056
[PubMed - indexed for MEDLINE]
8.

Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer.

Matsubayashi H, Infante JR, Winter J, Klein AP, Schulick R, Hruban R, Visvanathan K, Goggins M.

Cancer Biol Ther. 2007 Oct;6(10):1569-75. Epub 2007 Jul 9.

PMID:
18000398
[PubMed - indexed for MEDLINE]
Free Article
9.

Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.

Xu W, Li JY, Wu YJ, Yu H, Shen QD, Li L, Fan L, Qiu HX.

Leuk Res. 2008 Jul;32(7):1071-7. Epub 2007 Nov 26.

PMID:
18035414
[PubMed - indexed for MEDLINE]
10.

Immunohistochemically detected expression of 3 major genes (CDKN2A/p16, TP53, and SMAD4/DPC4) strongly predicts survival in patients with resectable pancreatic cancer.

Oshima M, Okano K, Muraki S, Haba R, Maeba T, Suzuki Y, Yachida S.

Ann Surg. 2013 Aug;258(2):336-46. doi: 10.1097/SLA.0b013e3182827a65.

PMID:
23470568
[PubMed - indexed for MEDLINE]
11.

Low expression levels of ATM may substitute for CHEK2 /TP53 mutations predicting resistance towards anthracycline and mitomycin chemotherapy in breast cancer.

Knappskog S, Chrisanthar R, Løkkevik E, Anker G, Østenstad B, Lundgren S, Risberg T, Mjaaland I, Leirvaag B, Miletic H, Lønning PE.

Breast Cancer Res. 2012 Mar 15;14(2):R47.

PMID:
22420423
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Lower ataxia telangiectasia mutated (ATM) mRNA expression is correlated with poor outcome of laryngeal and pharyngeal cancer patients.

Lee KW, Tsai YS, Chiang FY, Huang JL, Ho KY, Yang YH, Kuo WR, Chen MK, Lin CS.

Ann Oncol. 2011 May;22(5):1088-93. doi: 10.1093/annonc/mdq569. Epub 2010 Dec 1.

PMID:
21127011
[PubMed - indexed for MEDLINE]
Free Article
13.

Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.

Greipp PT, Smoley SA, Viswanatha DS, Frederick LS, Rabe KG, Sharma RG, Slager SL, Van Dyke DL, Shanafelt TD, Tschumper RC, Zent CS.

Br J Haematol. 2013 Nov;163(3):326-33. doi: 10.1111/bjh.12534. Epub 2013 Aug 27.

PMID:
24032430
[PubMed - indexed for MEDLINE]
14.

Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is associated with CIN.

Beggs AD, Domingo E, McGregor M, Presz M, Johnstone E, Midgley R, Kerr D, Oukrif D, Novelli M, Abulafi M, Hodgson SV, Fadhil W, Ilyas M, Tomlinson IP.

Oncotarget. 2012 Nov;3(11):1348-55.

PMID:
23154512
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor.

Shin JU, Lee CH, Lee KT, Lee JK, Lee KH, Kim KM, Kim KM, Park SM, Rhee JC.

Tumour Biol. 2012 Oct;33(5):1645-51. doi: 10.1007/s13277-012-0420-5. Epub 2012 Jun 16.

PMID:
22707287
[PubMed - indexed for MEDLINE]
16.

Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.

Skowronska A, Parker A, Ahmed G, Oldreive C, Davis Z, Richards S, Dyer M, Matutes E, Gonzalez D, Taylor AM, Moss P, Thomas P, Oscier D, Stankovic T.

J Clin Oncol. 2012 Dec 20;30(36):4524-32. doi: 10.1200/JCO.2011.41.0852. Epub 2012 Oct 22.

PMID:
23091097
[PubMed - indexed for MEDLINE]
Free Article
17.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2. Epub 2009 May 6.

PMID:
19418101
[PubMed - indexed for MEDLINE]
18.

Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer.

Laurberg JR, Brems-Eskildsen AS, Nordentoft I, Fristrup N, Schepeler T, Ulhøi BP, Agerbaek M, Hartmann A, Bertz S, Wittlinger M, Fietkau R, Rödel C, Borre M, Jensen JB, Orntoft T, Dyrskjøt L.

BJU Int. 2012 Dec;110(11 Pt C):E1228-36. doi: 10.1111/j.1464-410X.2012.11564.x. Epub 2012 Oct 9.

PMID:
23046361
[PubMed - indexed for MEDLINE]
19.

Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas.

Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M.

Br J Cancer. 2011 Apr 12;104(8):1296-302. doi: 10.1038/bjc.2011.93. Epub 2011 Mar 29.

PMID:
21448168
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Comparison of ataxia-telangiectasia mutated protein expression in diffuse large B-cell lymphomas of primary central nervous system and non-central nervous system origin.

Kim SH, Cheong JW, Park KH, Kim TS, Yang WI.

Arch Pathol Lab Med. 2007 Mar;131(3):457-67.

PMID:
17516749
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk